Specific molecular targeting of renal injury in obstructive nephropathy

Kidney International

Volumn 70, Issue 7, 2006, Pages 1200-1201

  Chevalier, R L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; EPIDERMAL GROWTH FACTOR; HERMES ANTIGEN; IN 1130; PROTEIN TYROSINE KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; DISEASE COURSE; DRUG SPECIFICITY; DRUG TARGETING; HUMAN; INFLAMMATION; INFLAMMATORY INFILTRATE; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; URETER OBSTRUCTION;

EID: 33748936323     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001815     Document Type: Note

References (12)

1. Chevalier RL. Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr 2006; 18: 153-160
2. Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol 2006; 2: 157-168
3. Chevalier RL, Cachat F. Role of angiotensin II in chronic ureteral obstruction. In: Wolf, G (ed.), The Renin-Angiotensin System and Progression of Renal Diseases, 1st edn. Basel: Karger, 2001, pp 250-260
4. Moon JA, Kim HT, Cho IS et al. IN-1130, a novel TGF-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 2006; 70: 1234-1243
5. Yang J, Zhang X, Li Y, Liu Y. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling. J Am Soc Nephrol 2003; 14: 3167-3177
6. Bascands JL, Schanstra JP. Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005; 68: 925-937
7. Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 2002; 13: 2464-2477
8. Imai E. Gene therapy for renal diseases: its potential and limitation. J Am Soc Nephrol 2003; 14: 1102-1104
9. Rouschop KMA, Sewnath ME, Claessen N et al. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2004; 15: 674-686
10. Yukawa K, Kishino M, Hoshino K et al. The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy. Int J Mol Med 2005; 15: 73-78
11. Kiley SC, Thornhill BA, Tang SS et al. Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int 2003; 63: 33-42
12. Kiley SC, Thornhill BA, Belyea BC et al. Epidermal growth factor potentiates renal cell death in hydronephrotic neonatal mice, but cell survival in rats. Kidney Int 2005; 68: 504-514